Real world data (RWD) reduces study costs, accelerates timelines and shortens time to market

  • RWD and RWE bring increasing value to pharmaceutical and medical technology (MedTech) companies to accelerate study timelines, shorten time to market, demonstrate safety and efficacy, and even maximize commercial success
  • In a published report based on a 2020 industry survey, more than 80% of responding companies indicated they are entering into strategic partnerships to access new sources of RWD
  • There is a marked increase in the prevalence and value that RWE/RWD will continue to provide to pharmaceutical and MedTech companies throughout a products lifecycle

Click here to learn more.

About SVMPharma

SVMPharma is an innovative strategic consultancy, specialising in Real-World Evidence (RWE) for the pharmaceutical industry. SVMPharma generates RWE within UK and Europe through bespoke online Real-World Treatment Evaluators, leading to successful health technology appraisal (HTA) submissions. Clinical trial programmes do not reflect real-world clinical practice and outcomes, RWE supplements and enhances clinical datasets. SVMPharma’s specialist teams focus on delivering the outcomes that matter to your brand.

For more information, please visit and contact us at

ref: APR2021CW002